Trial site
Hong Kong
- 20running trials
- 13closed trials
The trials here
What the 33 trials at this site are about, from their registry records.
- Conditions
- Lung cancer9 trials
- Colorectal cancer5 trials
- Coronary artery disease4 trials
- Prostate cancer3 trials
- Stroke3 trials
- Acute myeloid leukaemia2 trials
- Childhood cancers2 trials
- Chronic myeloid leukaemia2 trials
- Chronic spontaneous urticaria2 trials
- Diffuse large B-cell lymphoma2 trials
- Familial hypercholesterolaemia2 trials
- Head and neck cancer2 trials
- and 19 more
- Phase
- Phase 314 trials
- Phase 19 trials
- Phase 24 trials
- Phase 43 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Status
- Active, not recruiting14 trials
- Terminated7 trials
- Completed6 trials
- Recruiting6 trials
- Lead sponsor
- Novartis Pharmaceuticals33 trials
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Active, not recruiting
Active, not recruiting
Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer3 recruiting
- Aortic stenosis1 recruiting
- Chronic spontaneous urticaria1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
- IgA nephropathy1 recruiting
Closed trials
Terminated
Terminated
Completed
Terminated
Terminated
Completed
Terminated
Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Terminated
Completed
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
Completed
Terminated
Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026